Search

How is the OTC industry rising to pharma's biggest challenges?

How individually coded vials give manufacturers the ability to track vials moving through fill and finish lines.

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Join this webinar to learn what attributes across the manufacturing process impact quality.

Efficient data management is critical to meet the demand for fast drug development – especially in light of COVID-19

Experts from the BIA got together to discuss how the UK’s biotechnology industry can plug the UK’s worrying skills gap.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Is there data demonstrating significant cost benefits from continuous biomanufacturing?